CLDX Celldex Therapeutics shares down 2.6% after scrapping development of skin disease drug
CLDX Celldex Therapeutics shares down 2.6% after scrapping development of skin disease drug
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CLDX Celldex Therapeutics shares down 2.6% after scrapping development of skin disease drug